Evidence-based guideline: The role of diffusion and perfusion MRI for the diagnosis of acute ischemic stroke
暂无分享,去创建一个
R. Edelman | S. Warach | J. Detre | R. Bryan | C. Kidwell | L. Caplan | P. Schellinger | M. Sloan | J. Mohr | C. Jaigobin | A. G. Sorensen
[1] H. Jinnah,et al. Animal models of generalized dystonia , 2005, NeuroRX.
[2] K. Trinkaus,et al. Increased diffusivity in acute multiple sclerosis lesions predicts risk of black hole , 2010, Neurology.
[3] S. Warach,et al. Recommendations for imaging of acute ischemic stroke: a scientific statement from the American Heart Association. , 2009, Stroke.
[4] Jeffrey L Saver,et al. Expansion of the time window for treatment of acute ischemic stroke with intravenous tissue plasminogen activator: a science advisory from the American Heart Association/American Stroke Association. , 2009, Stroke.
[5] R. Corominas,et al. Late-onset episodic ataxia type 2 associated with a novel loss-of-function mutation in the CACNA1A gene , 2009, Journal of the Neurological Sciences.
[6] Lee Schwamm,et al. Cost-effectiveness of patient selection using penumbral-based MRI for intravenous thrombolysis. , 2009, Stroke.
[7] S. Warach,et al. Intravenous desmoteplase in patients with acute ischaemic stroke selected by MRI perfusion–diffusion weighted imaging or perfusion CT (DIAS-2): a prospective, randomised, double-blind, placebo-controlled study , 2009, The Lancet Neurology.
[8] L. Østergaard,et al. Safety and Efficacy of MRI-Based Selection for Recombinant Tissue Plasminogen Activator Treatment: Responder Analysis of Outcome in the 3-Hour Time Window , 2009, Cerebrovascular Diseases.
[9] D. Mozaffarian,et al. Heart disease and stroke statistics--2009 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. , 2009, Circulation.
[10] D. Mozaffarian,et al. Heart disease and stroke statistics--2009 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. , 2009, Circulation.
[11] G. Gronseth,et al. Invited Article: Practice parameters and technology assessments , 2008, Neurology.
[12] P. Lyden,et al. Thrombolytic therapy for acute stroke--not a moment to lose. , 2008, The New England journal of medicine.
[13] M. Kaste,et al. Thrombolysis with alteplase 3 to 4.5 hours after acute ischemic stroke. , 2008, The New England journal of medicine.
[14] T. Zwingman,et al. Two novel alleles of tottering with distinct Ca(v)2.1 calcium channel neuropathologies , 2008, Neuroscience.
[15] Keith Muir,et al. Effects of alteplase beyond 3 h after stroke in the Echoplanar Imaging Thrombolytic Evaluation Trial (EPITHET): a placebo-controlled randomised trial , 2008, The Lancet Neurology.
[16] H. Jinnah,et al. Paroxysmal dyskinesias in mice , 2008, Movement disorders : official journal of the Movement Disorder Society.
[17] J. Roder,et al. Forward genetic screen of mouse reveals dominant missense mutation in the P/Q‐type voltage‐dependent calcium channel, CACNA1A , 2007, Genes, brain, and behavior.
[18] T. Neumann-Haefelin,et al. MRI-Based and CT-Based Thrombolytic Therapy in Acute Stroke Within and Beyond Established Time Windows: An Analysis of 1210 Patients , 2007, Stroke.
[19] Adnan I. Qureshi,et al. Guidelines for the Early Management of Adults With Ischemic Stroke , 2007 .
[20] M. Luby,et al. Magnetic resonance imaging and computed tomography in emergency assessment of patients with suspected acute stroke: a prospective comparison , 2007, The Lancet.
[21] Scott Hamilton,et al. Magnetic resonance imaging profiles predict clinical response to early reperfusion: The diffusion and perfusion imaging evaluation for understanding stroke evolution (DEFUSE) study , 2006, Annals of neurology.
[22] Steven Warach,et al. Dose Escalation of Desmoteplase for Acute Ischemic Stroke (DEDAS): Evidence of Safety and Efficacy 3 to 9 Hours After Stroke Onset , 2006, Stroke.
[23] R Frayne,et al. Imaging of the brain in acute ischaemic stroke: comparison of computed tomography and magnetic resonance diffusion-weighted imaging , 2005, Journal of Neurology, Neurosurgery & Psychiatry.
[24] S. Warach,et al. MRI Screening Before Standard Tissue Plasminogen Activator Therapy Is Feasible and Safe , 2005, Stroke.
[25] T. Bird,et al. Two novel CACNA1A gene mutations associated with episodic ataxia type 2 and interictal dystonia. , 2005, Archives of neurology.
[26] S. Warach,et al. The Desmoteplase in Acute Ischemic Stroke Trial (DIAS): A Phase II MRI-Based 9-Hour Window Acute Stroke Thrombolysis Trial With Intravenous Desmoteplase , 2005, Stroke.
[27] John A Butman,et al. Comparison of MRI and CT for detection of acute intracerebral hemorrhage. , 2004, JAMA.
[28] A. Villringer,et al. Stroke Magnetic Resonance Imaging Is Accurate in Hyperacute Intracerebral Hemorrhage: A Multicenter Study on the Validity of Stroke Imaging , 2004, Stroke.
[29] P. Bossuyt,et al. BMC Medical Research Methodology , 2002 .
[30] B. Buckley,et al. Audit of a policy of magnetic resonance imaging with diffusion-weighted imaging as first-line neuroimaging for in-patients with clinically suspected acute stroke. , 2003, Clinical radiology.
[31] Werner Hacke,et al. Imaging-Based Decision Making in Thrombolytic Therapy for Ischemic Stroke: Present Status , 2003, Stroke.
[32] David Moher,et al. Towards complete and accurate reporting of studies of diagnostic accuracy: the STARD initiative. Standards for Reporting of Diagnostic Accuracy. , 2003, Clinical chemistry.
[33] Stroke neuroimaging. , 2003, Stroke.
[34] M. Laakso,et al. Apolipoprotein E Polymorphism and Acute Ischemic Stroke: A Diffusion- and Perfusion-Weighted Magnetic Resonance Imaging Study , 2002, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[35] A Gregory Sorensen,et al. Predicting cerebral ischemic infarct volume with diffusion and perfusion MR imaging. , 2002, AJNR. American journal of neuroradiology.
[36] Joana,et al. Neuroimaging , 2002 .
[37] A. Jaillard. Reply to the Paper by von Kummer et al.: Imaging of Stroke Pathology without Predefined Gold Standard , 2002, Cerebrovascular Diseases.
[38] R. von Kummer. Imaging of Stroke Pathology without Predefined Gold Standard , 2002, Cerebrovascular Diseases.
[39] W. Hacke,et al. CT and Diffusion-Weighted MR Imaging in Randomized Order: Diffusion-Weighted Imaging Results in Higher Accuracy and Lower Interrater Variability in the Diagnosis of Hyperacute Ischemic Stroke , 2002, Stroke.
[40] G. Schlaug,et al. Is the Association of National Institutes of Health Stroke Scale Scores and Acute Magnetic Resonance Imaging Stroke Volume Equal for Patients With Right- and Left-Hemisphere Ischemic Stroke? , 2002, Stroke.
[41] Gereon R Fink,et al. MR imaging in acute stroke: diffusion-weighted and perfusion imaging parameters for predicting infarct size. , 2002, Radiology.
[42] J. Jankovic,et al. Dystonia in spinocerebellar ataxia type 6 , 2002, Movement disorders : official journal of the Movement Disorder Society.
[43] J. Grotta,et al. Lack of clinical significance of early ischemic changes on computed tomography in acute stroke. , 2001, JAMA.
[44] M. Knauth,et al. Comparison of CT with diffusion-weighted MRI in patients with hyperacute stroke , 2001, Neuroradiology.
[45] Leif Østergaard,et al. Diffusion and perfusion MR imaging in acute ischemic stroke: a comparison to SPECT , 2001, Comput. Methods Programs Biomed..
[46] Brian Silver,et al. A three-item scale for the early prediction of stroke recovery , 2001, The Lancet.
[47] G. Cosnard,et al. Usefulness of Magnetic Resonance-Derived Quantitative Measurements of Cerebral Blood Flow and Volume in Prediction of Infarct Growth in Hyperacute Stroke , 2001, Stroke.
[48] C. Fletcher,et al. Dystonia and cerebellar atrophy in Cacna1a null mice lacking P/Q calcium channel activity , 2001, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[49] G. Schlaug,et al. Diffusion-weighted imaging and National Institutes of Health Stroke Scale in the acute phase of posterior-circulation stroke. , 2001, Archives of neurology.
[50] S. Warach,et al. Effect of citicoline on ischemic lesions as measured by diffusion‐weighted magnetic resonance imaging , 2000 .
[51] M E Moseley,et al. Is Early Ischemic Lesion Volume on Diffusion-Weighted Imaging an Independent Predictor of Stroke Outcome?: A Multivariable Analysis , 2000, Stroke.
[52] W Hacke,et al. Feasibility and practicality of MR imaging of stroke in the management of hyperacute cerebral ischemia. , 2000, AJNR. American journal of neuroradiology.
[53] A. Demchuk,et al. Validity and reliability of a quantitative computed tomography score in predicting outcome of hyperacute stroke before thrombolytic therapy , 2000, The Lancet.
[54] A. Demchuk,et al. Validity and reliability of a quantitative computed tomography score in predicting outcome of hyperacute stroke before thrombolytic therapy. ASPECTS Study Group. Alberta Stroke Programme Early CT Score. , 2000, Lancet.
[55] S. Warach,et al. Effect of citicoline on ischemic lesions as measured by diffusion-weighted magnetic resonance imaging. Citicoline 010 Investigators. , 2000, Annals of neurology.
[56] S M Davis,et al. Identification of major ischemic change. Diffusion-weighted imaging versus computed tomography. , 1999, Stroke.
[57] K. Welch,et al. Total quality improvement method for reduction of delays between emergency department admission and treatment of acute ischemic stroke. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. , 1997, Archives of neurology.
[58] L Bozzao,et al. Acute stroke: usefulness of early CT findings before thrombolytic therapy. , 1997, Radiology.
[59] H. Ellis. stroke , 1997, The Lancet.
[60] Gottfried Schlaug,et al. Ischemic lesion volumes in acute stroke by diffusion‐weighted magnetic resonance imaging correlate with clinical outcome , 1997, Annals of neurology.
[61] E. Hess,et al. Migraines in Mice? , 1996, Cell.
[62] Koroshetz Wj,et al. Tissue plasminogen activator for acute ischemic stroke. , 1996, The New England journal of medicine.
[63] Joseph P. Broderick,et al. Tissue plasminogen activator for acute ischemic stroke. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. , 1995 .
[64] C. Manelfe,et al. Early CT Diagnosis of Hemispheric Brain Infarction , 1995, Springer Berlin Heidelberg.
[65] J. Kucharczyk,et al. Early detection of regional cerebral ischemia in cats: Comparison of diffusion‐ and T2‐weighted MRI and spectroscopy , 1990, Magnetic resonance in medicine.
[66] B. Rosen,et al. Perfusion imaging with NMR contrast agents , 1990, Magnetic resonance in medicine.
[67] E. O. Bregman,et al. The Present Status. , 1926 .